Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial
- PMID: 6376294
- DOI: 10.1016/0090-8258(84)90030-1
Perioperative external pneumatic calf compression as thromboembolism prophylaxis in gynecologic oncology: report of a randomized controlled trial
Abstract
Postoperative venous thromboembolic complications are a major problem for the gynecologic oncologist. External pneumatic calf compression (EPC), when applied intraoperatively and left on the patient's legs for 5 days postoperatively, has been previously demonstrated to significantly reduce the incidence of venous thromboembolic complications in patients undergoing surgery for pelvic malignancies. The purpose of this study is to evaluate whether a short perioperative course of EPC is also effective in preventing venous thromboembolic complications. One hundred ninety-four patients participated in a randomized controlled trial of perioperative external pneumatic calf compression. 125I-labeled fibrinogen scanning and impedance plethysmography were used as prospective surveillance methods in both groups. Venous thromboembolic complications were diagnosed in 12.4% of control group patients and in 18.6% of EPC group patients. External pneumatic calf compression when used only in the perioperative period appears to be of no benefit in reducing the incidence of postoperative venous thromboembolic complications.
Similar articles
-
Prevention of postoperative venous thromboembolism by external pneumatic calf compression in patients with gynecologic malignancy.Obstet Gynecol. 1984 Jan;63(1):92-8. Obstet Gynecol. 1984. PMID: 6691021
-
Venous thromboembolism prophylaxis in gynecologic oncology: a prospective, controlled trial of low-dose heparin.Am J Obstet Gynecol. 1983 Mar 1;145(5):606-13. doi: 10.1016/0002-9378(83)91205-x. Am J Obstet Gynecol. 1983. PMID: 6338722 Clinical Trial.
-
Pneumatic compression versus low molecular weight heparin in gynecologic oncology surgery: a randomized trial.Obstet Gynecol. 2001 Dec;98(6):989-95. doi: 10.1016/s0029-7844(01)01601-5. Obstet Gynecol. 2001. PMID: 11755543 Clinical Trial.
-
Prevention of venous thromboembolism.Semin Thromb Hemost. 1976 Apr;2(4):232-90. doi: 10.1055/s-0028-1086126. Semin Thromb Hemost. 1976. PMID: 798276 Review.
-
Prophylaxis against thromboembolism in gynecologic patients.J Reprod Med. 1984 Dec;29(12):845-62. J Reprod Med. 1984. PMID: 6084062 Review.
Cited by
-
American Society of Hematology 2019 guidelines for management of venous thromboembolism: prevention of venous thromboembolism in surgical hospitalized patients.Blood Adv. 2019 Dec 10;3(23):3898-3944. doi: 10.1182/bloodadvances.2019000975. Blood Adv. 2019. PMID: 31794602 Free PMC article.
-
Hemostatic alterations in cancer patients.Cancer Metastasis Rev. 1992 Nov;11(3-4):237-48. doi: 10.1007/BF01307180. Cancer Metastasis Rev. 1992. PMID: 1423816 Review.
-
Prevention of venous thromboembolism in general surgical patients. Results of meta-analysis.Ann Surg. 1988 Aug;208(2):227-40. doi: 10.1097/00000658-198808000-00016. Ann Surg. 1988. PMID: 2456748 Free PMC article. Review.
-
Efficacy and safety of thromboprophylaxis in cancer patients: a systematic review and meta-analysis.Ther Adv Med Oncol. 2020 Mar 18;12:1758835920907540. doi: 10.1177/1758835920907540. eCollection 2020. Ther Adv Med Oncol. 2020. PMID: 32215058 Free PMC article.
-
Cancer-associated thrombosis: prevention and treatment.Curr Oncol. 2008 Jan;15(Suppl 1):S58-67. doi: 10.3747/co.2008.177. Curr Oncol. 2008. PMID: 18231650 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical